Chefsöverläkare NHV Ätstörningar

Edubrain educates on brain health and disease

Clinical Psychiatry; Institutional Psychiatric treatment and care.Since 2015, Attending Psychiatrist, Leading Eating disorder and weight restoration unit in-patient care

Since June 2015 employed by Copenhagen University, Insititute for Clinical Medicine, section Psychiatry, as Lecturer. From 1st August 2016, Sr Lecturer/Research position. Focus is Research on Eating Disorders

DiaGenic ASA is an innovative Norwegian in vitro diagnostic company founded in 1998 and listed on the Oslo Stock Exchange since 2004. DiaGenic develops patient-friendly diagnostic tests for the early detection of devastating diseases where early intervention is crucial for successful treatment. DiaGenic's patented method is based on identifying disease-specific gene expression signatures from easily available sample biomaterial such as blood.DiaGenic's first two products, ADtect® for early detection of Alzheimer's disease and BCtect® for early detection of breast cancer, have received regulatory approval for Europe, CE mark.DiaGenic has an existing pipeline of early and late stage gene expression (signature) products for Parkinson's Disease and for the diagnostic work-up of amnestic Mild Cognitive Impairment that are prone to develop Alzheimer's disease dementia within 2 years.The diagnostic tests together with R&D collaborations with major pharmaceutical companies forms the basis of the company's biomarker strategy enabling early disease detection for clinical trials.

Strategy and Management lead in early clinical development; Implement new organization in Exploratory development; manage and improve internal communications/relations and work-flow; and much more

Preclinical research on tau phosphorylation and cell cycle processess in neurodegenerative disorders

Global Head of Translational medicine, covering all Therapeutic Areas of interest to Schering-Plough, leads a department of 13 positions which includes 10 post-doc clinical scientists and 3 Pharmacogenomics assistants. The focus is on early clinical translational models, biomarkers for decision making, Pharmacogenomics, Theranostics, clinical assays, human biobank.Schering-Plough is a global top 10 Pharmaceutical Industry company.

Translational Medicine, Clinical development and Neuroscience strategy

Chair of Translational medicine board for NeuroscienceChair of global platform for Cognitive testing in R&DFocus on early clinical models in Neuroscience